The effects of APOE genotype on age at onset and progression of neurodegenerative diseases

被引:54
作者
Chapman, J
Korczyn, AD
Karussis, DM
Michaelson, DM [1 ]
机构
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69789 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-69978 Tel Aviv, Israel
[4] Hadassah Med Ctr, Dept Neurol, IL-91120 Jerusalem, Israel
关键词
D O I
10.1212/WNL.57.8.1482
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
APOE genotype influences the age at onset of some neurodegenerative diseases such as AD and the rate of progression in others such as MS. The authors hypothesize that APOE genotype ubiquitously determines the efficacy of neuronal maintenance and repair in these diseases and that the seemingly divergent clinical effects are due to the stage of disease at which the diagnosis is made. Early diagnosis facilitates the measurement of effects on disease progression rate, whereas late diagnosis results in a marked effect of APOE genotype on disease onset.
引用
收藏
页码:1482 / 1485
页数:4
相关论文
共 58 条
[11]   APOE in non-Alzheimer amyloidoses -: Transmissible spongiform encephalopathies [J].
Chapman, J ;
Cervenáková, L ;
Lee, HS ;
Estupinan, J ;
Richardson, S ;
Vnencak-Jones, CL ;
Gajdusek, DC ;
Korczyn, AD ;
Brown, P ;
Goldfarb, LG .
NEUROLOGY, 1998, 51 (02) :548-553
[12]   PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE [J].
CORDER, EH ;
SAUNDERS, AM ;
RISCH, NJ ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
RIMMLER, JB ;
LOCKE, PA ;
CONNEALLY, PM ;
SCHMADER, KE ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
NATURE GENETICS, 1994, 7 (02) :180-184
[13]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[14]   Accelerated decline in apolipoprotein E-ε4 homozygotes with Alzheimer's disease [J].
Craft, S ;
Teri, L ;
Edland, SD ;
Kukull, WA ;
Schellenberg, G ;
McCormick, WC ;
Bowen, JD ;
Larson, EB .
NEUROLOGY, 1998, 51 (01) :149-153
[15]  
DalForno G, 1996, ARCH NEUROL-CHICAGO, V53, P345
[16]   Association of the APOE ε4 allele with disease activity in multiple sclerosis [J].
Evangelou, N ;
Jackson, M ;
Beeson, D ;
Palace, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (02) :203-205
[17]   Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis [J].
Fazekas, F ;
Strasser-Fuchs, S ;
Schmidt, H ;
Enzinger, C ;
Ropele, S ;
Lechner, A ;
Flooh, E ;
Schmidt, R ;
Hartung, HP .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (01) :25-28
[18]   Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injury [J].
Friedman, G ;
Froom, P ;
Sazbon, L ;
Grinblatt, I ;
Shochina, M ;
Tsenter, J ;
Babaey, S ;
Ben Yehuda, A ;
Groswasser, Z .
NEUROLOGY, 1999, 52 (02) :244-248
[19]   ALZHEIMERS-DISEASE WITH AND WITHOUT COEXISTING PARKINSONS-DISEASE CHANGES - APOLIPOPROTEIN-E GENOTYPE AND NEUROPATHOLOGIC CORRELATES [J].
GEARING, M ;
SCHNEIDER, JA ;
REBECK, GW ;
HYMAN, BT ;
MIRRA, SS .
NEUROLOGY, 1995, 45 (11) :1985-1990
[20]   Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease [J].
GomezIsla, T ;
West, HL ;
Rebeck, GW ;
Harr, SD ;
Growdon, JH ;
Locascio, JJ ;
Perls, TT ;
Lipsitz, LA ;
Hyman, BT .
ANNALS OF NEUROLOGY, 1996, 39 (01) :62-70